Drug donations to Bosnia-Hercegovina are often inappropriate

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7063.1011b (Published 19 October 1996) Cite this as: BMJ 1996;313:1011
  1. Maurizio Bonati, Head,
  2. Gilles B Forte, Adviser,
  3. Kees DE Joncheere, Regional adviser for pharmaceuticals,
  4. Einar Magnusson, Director
  1. Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy
  2. Programme for Pharmaceuticals, World Health Organisation, Regional Office for Europe, DK-2100 Copenhagen, Denmark
  3. Pharmaceutical Affairs, Ministry of Health and Social Security, IS-150 Reykjavik, Iceland

    EDITOR,—The programme for pharmaceuticals of the World Health Organisation's Regional Office for Europe recently carried out a situation analysis of the pharmaceuticals in Bosnia-Hercegovina. One striking finding was the large amount of unused drugs that originated from donations. This finding is not exclusive to Bosnia-Hercegovina, and urgent action is needed to prevent such situations in countries in transition.

    In Bosnia-Hercegovina 70–80% of drugs were reported to have been provided by humanitarian organisations, charities, and groups of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription